Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 6 de may. de 2024 · Asthma cannot be cured but there are several treatments available. The most common treatment is to use an inhaler, which delivers medication directly to the lungs. Inhalers can help control the disease and enable people with asthma to enjoy a normal, active life.

  2. 15 de may. de 2020 · Inhaled medication can control asthma symptoms and allow people with asthma to lead a normal, active life. Through appropriate treatment such as using inhaled corticosteroids to ease bronchial inflammation, the number of asthma exacerbation and asthma-related deaths can be reduced.

  3. Scheduled, daily inhaled corticosteroid (ICS) treatment is the currently preferred pharmacologic controller therapy for persistent asthma in individuals of all ages. Intermittent ICS dosing includes courses of ICS treatment used for brief periods, usually in response to symptoms or as an add-on with or without a long-acting beta 2-agonist (LABA).

  4. 7 de may. de 2024 · The 2022 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.

  5. 2 de may. de 2023 · Inhalers are the safest, most effective treatment for asthma and allow people with asthma to lead a normal, active life. 4. Use a spacer. A spacer is a plastic chamber which connects the inhaler at one end, to your mouth via a mouthpiece or mask at the other end. It can help inhaled medicines to reach the small airways in the lungs and work better.

  6. 1 de ene. de 2022 · Supplementary Materials. The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention, which can be adapted for local circumstances ( e.g. medication availability).

  7. For individuals with mild to moderate persistent asthma who are taking daily ICS treatment (likely adherent with prescribed daily ICS) as a controller, increasing the regular daily ICS dose for short periods is not recommended when symptoms increase or peak flow decreases.